ZGNX

Zogenix Update on Legal Action

[PR Newswire] – SAN DIEGO, April 8, 2014 /PRNewswire/ — Today Zogenix presented its case in U.S. District Court in Boston requesting an immediate order staying the ban on the U.S. Food and Drug Administration (FDA)-approved … moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring next, click […]

States rebel against powerful new painkiller

moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring next, click here to view […]

FDA, HHS Reaffirm Support for Chronic Pain Patients Amid Zohydro ER Debate

[PR Newswire] – SAN DIEGO, April 4, 2014 /PRNewswire/ — Today, Health and Human Services (HHS) Secretary Kathleen Sebelius, and U.S. Food and Drug Administration (FDA) Commissioner Dr. Margaret Hamburg, called for a balanced approach in the fight agains moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring […]

Zogenix Statement: Let’s Get the Facts Straight About Zohydro ER

[PR Newswire] – SAN DIEGO, April 2, 2014 /PRNewswire/ — We are extremely disappointed that the U.S. Drug Enforcement Administration (DEA) Administrator, as she did in a Congressional hearing today, would repeat misinformation … moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring next, click here to view […]